AR081772A1 - Tratamiento de la artritis reumatoide con masitinib - Google Patents

Tratamiento de la artritis reumatoide con masitinib

Info

Publication number
AR081772A1
AR081772A1 ARP110101884A ARP110101884A AR081772A1 AR 081772 A1 AR081772 A1 AR 081772A1 AR P110101884 A ARP110101884 A AR P110101884A AR P110101884 A ARP110101884 A AR P110101884A AR 081772 A1 AR081772 A1 AR 081772A1
Authority
AR
Argentina
Prior art keywords
treatment
masitinib
reumatoid arthritis
arthritis
reumatoid
Prior art date
Application number
ARP110101884A
Other languages
English (en)
Inventor
Alain Moussy
Jean-Pierre Kinet
Original Assignee
Ab Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Science filed Critical Ab Science
Publication of AR081772A1 publication Critical patent/AR081772A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

Un inhibidor de la tirosina quinasa o un inhibidor de los mastocitos, y en particular masitinib o una sal farmacéuticamente aceptable del mismo, para el tratamiento de la artritis reumatoide humana.
ARP110101884A 2010-06-02 2011-06-01 Tratamiento de la artritis reumatoide con masitinib AR081772A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35060310P 2010-06-02 2010-06-02

Publications (1)

Publication Number Publication Date
AR081772A1 true AR081772A1 (es) 2012-10-17

Family

ID=44119407

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101884A AR081772A1 (es) 2010-06-02 2011-06-01 Tratamiento de la artritis reumatoide con masitinib

Country Status (4)

Country Link
US (1) US20130267484A1 (es)
AR (1) AR081772A1 (es)
TW (1) TW201204719A (es)
WO (1) WO2011151372A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
WO2018045258A1 (en) * 2016-09-02 2018-03-08 The University Of Chicago TREATMENT OF TNF-alpha CYTOTOXICITY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ530764A (en) * 2001-07-09 2008-07-31 Combinatorx Inc Composition comprising a tricyclic antidepressant and a corticosteroid administered simutaneously or within 14 days for treatment of inflammatory disorders
DK1525200T3 (da) 2002-08-02 2007-12-03 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazoler til sygdomsbehandling
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US8073630B2 (en) * 2006-08-30 2011-12-06 Exagen Diagnostics, Inc. Pharacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis
NZ578944A (en) 2007-02-13 2011-03-31 Ab Science PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS SUCH AS 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide AS KINASE INHIBITORS

Also Published As

Publication number Publication date
WO2011151372A1 (en) 2011-12-08
US20130267484A1 (en) 2013-10-10
TW201204719A (en) 2012-02-01

Similar Documents

Publication Publication Date Title
EA201300810A1 (ru) Противораковая терапия с использованием двойных ингибиторов киназ аврора/мек
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
UY34387A (es) Composiciones para el tratamiento de la artritis reumatoide y métodos para su utilización.
SMT201600430B (it) Inibitori di chinasi e loro uso nel trattamento del cancro
CL2015000829A1 (es) Inhibidores de histona desmetilasas
CR10995A (es) Inhibidores de la actividad de akt
CL2012003385A1 (es) Tratamiento para la incontinencia.
DOP2012000105A (es) Compuestos de espiropiperidina y uso farmaceutico del mismo para tratar la diabetes
CL2015000094A1 (es) Compuestos derivados de imidazotriazincarbonitrilos, inhibidores de la proteina cinasa; composicion farmaceutica que los comprende; y su uso para tratar el cancer, psoriasis y artritis reumatoide.
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
DK3492455T3 (da) 1,2,4-triazoler som nukleare transportmodulatorer og anvendelse til behandling af specifikke former for cancer
EA201400178A1 (ru) Лечение рака молочной железы
CL2010001637A1 (es) Compuestos derivados de isoindolonas; composición farmacéutica que los comprende; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas y/o inflamatorias tales como cáncer, artritis reumatoidea entre otras.
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
UY34132A (es) Terapias combinadas para el tratamiento de neoplasias malignas hematológicas utilizando inhibidores de piridopirimidinona de pi3k/mtor con bendamustina y/o rituximab.
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
CO7020867A2 (es) Formulaciones de anticuerpo y metodos
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
UY35274A (es) Compuestos y métodos para tratar infecciones bacterianas
CL2014001861A1 (es) Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia.
GT201200345A (es) Compuestos heterocìclicos, su preparaciòn y su aplicaciòn terapèutica
CL2012003322A1 (es) Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer.
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina
AR080933A1 (es) Tratamiento de esclerosis multiple con masitinib

Legal Events

Date Code Title Description
FB Suspension of granting procedure